Regarding diagnosis, 96% (51/53) of astrocytomas were classified as ALT + (42 of which showed ATRX loss), along with 73% (14/19) of histone-mutant tumors, consistent with previous studies [15]. The gene discussed is GPT; the disease is astrocytoma (excluding glioblastoma).